SESN2, as a new p53 targeted gene, is involved in the induction of autophagy (Maiuri et al., 2009), and overexpression of SESN2 mediates the anti-cancer activity of Isorhapontigenin in bladder cancer cells (Liang et al., 2016). The gene discussed is SESN2; the disease is cancer.